医学
肠促胰岛素
兴奋剂
纤维化
内科学
活检
艾塞那肽
胃肠病学
泌尿科
2型糖尿病
糖尿病
内分泌学
受体
作者
Sudha S. Shankar,Samuel J. Daniels,Darren Robertson,Janeli Sarv,José Sánchez,Debra Carter,Lutz Jermutus,Benjamin Challis,Arun J. Sanyal
标识
DOI:10.1016/j.cgh.2024.04.017
摘要
Cotadutide, a peptide co-agonist at the glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptors, has demonstrated robust improvements in body weight, glycemia, and hepatic fat fraction (HFF) in patients living with obesity and type 2 diabetes mellitus.
科研通智能强力驱动
Strongly Powered by AbleSci AI